Clinical Trials

Showing trials with last updates posted in 2026.

NCT03739814 | RECRUITING | PHASE2
84 participants

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2019-05-08
Completion:
2027-02-01
Conditions
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • Recurrent B Acute Lymphoblastic Leukemia
  • Refractory B Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT03561376 | RECRUITING | EARLY_PHASE1
30 participants

Zinc Oxide Versus Petrolatum Following Skin Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2021-09-01
Completion:
2027-09-30
Conditions
  • Surgical Incision
  • Surgery--Complications
  • Surgical Wound
  • Surgical Site Infection
  • Scar
  • Hypertrophic Scar
Interventions
  • DRUG
No Results Yet
NCT03394365 | RECRUITING | PHASE3
115 participants

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2017-12-29
Completion:
2030-05-31
Conditions
  • Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
  • Solid Organ Transplant Complications
  • Lymphoproliferative Disorders
  • Allogeneic Hematopoietic Cell Transplant
  • Stem Cell Transplant Complications
Interventions
  • BIOLOGICAL
No Results Yet
NCT03317405 | ACTIVE_NOT_RECRUITING | PHASE1
32 participants

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2018-10-31
Completion:
2021-02-22
Conditions
  • Breast Carcinoma In Situ
  • Breast Ductal Carcinoma In Situ
  • Breast Lobular Carcinoma In Situ
  • Stage I Breast Cancer AJCC v7
  • Stage IA Breast Cancer AJCC v7
  • Stage IB Breast Cancer AJCC v7
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage IIA Breast Cancer AJCC v6 and v7
  • Stage IIB Breast Cancer AJCC v6 and v7
  • Stage III Breast Cancer AJCC v7
  • Stage IIIA Breast Cancer AJCC v7
  • Stage IIIB Breast Cancer AJCC v7
  • Stage IIIC Breast Cancer AJCC v7
Interventions
  • DRUG
  • OTHER
NCT02750826 | ACTIVE_NOT_RECRUITING | PHASE3
3177 participants

Breast Cancer WEight Loss Study (BWEL Study)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2016-09-16
Completion:
2030-05-30
Conditions
  • Breast Ductal Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage IIB Breast Cancer AJCC v6 and v7
  • Stage IIIA Breast Cancer AJCC v7
  • Stage IIIC Breast Cancer AJCC v7
  • Synchronous Bilateral Breast Carcinoma
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page